Retinoic acid, but not arsenic trioxide, degrades the PLZF/RARalpha fusion protein, without inducing terminal differentiation or apoptosis, in a RA-therapy resistant t(11;17)(q23;q21) APL patient.

Download in:

• JSON
• RDF
• N3/Turtle
• N-Triples

View as

• Triples